How do we get corneal crosslinking covered when payers deny it?
The young patient’s keratoconus is progressing, crosslinking can halt it, and the clinical case is not the hard part.
What Actually Gets a Crosslinking Case Approved
The goal is a progressing keratoconus patient scheduled on time because the coverage was worked to each plan’s own policy before the denial, not after. Here is what does that, move by move.
1. Read Each Plan’s Crosslinking Policy Before You Schedule
Coverage is not uniform, so you cannot work it uniformly. Before scheduling, pull the specific plan’s medical policy for corneal crosslinking: whether it covers the FDA-approved epi-off protocol, what progression documentation it requires, its age and diagnosis criteria, and whether it excludes off-label techniques. A plan that approves crosslinking and a plan that calls it investigational are reading different policies, and you cannot document to a rule you have not read.
2. Document Progression and the FDA-Approved Protocol
Most covered crosslinking cases turn on two things: documented progression of keratoconus and use of the FDA-approved epi-off protocol. Build the request around exactly that, the serial measurements that show progression, the diagnosis, the affected eye, and confirmation that the planned procedure follows the approved protocol rather than an off-label epi-on technique that plans routinely exclude. When the request matches what the policy actually covers, an approval has nothing to push back on.
3. Confirm Medicaid Coverage for Your State and Plan Up Front
A large share of keratoconus patients are on Medicaid, where coverage varies by state and by managed-care plan. Do not assume; confirm before scheduling whether the patient’s specific Medicaid plan covers crosslinking, what documentation it wants, and whether a prior authorization is required. Knowing the state and plan rule up front is what turns a case-by-case Medicaid battle into a prepared request, and it protects the patient from a denial that arrives after the procedure is already on the calendar.
4. Appeal an Investigational Denial With the Coverage Record
When a plan calls the FDA-approved procedure investigational, the appeal is a coverage argument, not a clinical one. The packet shows that the epi-off protocol is FDA-approved for progressive keratoconus, cites the plan’s own policy where it covers the procedure, and documents the progression that meets the criteria. An investigational label on an approved protocol is often a policy that has not caught up, and it is answered with the coverage record, filed before the appeal window closes.
5. Hand Crosslinking Auth to a Dedicated Team
Practices that stop losing crosslinking cases to coverage roulette do it by handing the authorization to a dedicated team: remote specialists who read each plan’s policy, document to it, confirm Medicaid by state, and appeal an investigational denial with the record, live in 1 to 2 weeks. The cornea surgeons go back to treating patients, a trained backup covers every gap, and the coverage queue stops being the thing nobody owns. Below is what it sounds like when nobody owns it yet, in providers’ own words.
Key Pain Points and Discussions by Providers
real reports from practice staff, lightly edited
“The clinical decision is easy. The coverage is the nightmare. One plan approves crosslinking without a fight and the next one calls the exact same procedure investigational, and I am left explaining to a family why their kid’s vision is on hold over policy language.” – ophthalmologist, cornea specialist
“So many of these keratoconus patients are on Medicaid, and the answer changes with the state and the managed-care plan. We have learned to confirm coverage before we ever put the procedure on the schedule, or we get burned.” – practice administrator, ophthalmology group
“We had an approval overturned as investigational even though the protocol is FDA-approved. The appeal that worked was not a medical argument at all; it was showing the plan its own policy and the approval status.” – prior authorization coordinator, eye practice
“The off-label technique question trips people up. If the request even hints at an epi-on approach, some plans deny it outright, so we document the approved protocol explicitly every time.” – surgical scheduler, cornea practice
“Every crosslinking denial we lost, we lost because the documentation did not match that specific plan’s policy. Once we started reading the policy first and building to it, the approvals started coming.” – billing lead, ophthalmology practice
Our Answer
Here is what we actually do. A dedicated remote specialist reads the specific plan’s crosslinking policy before you schedule, whether it covers the FDA-approved epi-off protocol, what progression documentation it wants, and whether it excludes off-label techniques, and builds the request to that policy. They document progression and the approved protocol explicitly, confirm Medicaid coverage for the patient’s state and plan up front, and when a plan calls the approved procedure investigational, they appeal with the coverage record and the plan’s own policy rather than a clinical argument. Everything is filed before the window closes so a covered patient does not wait on a battle. Our specialists are clinically trained team members working under US-licensed nurse and pharmacist quality review, inside your systems during US business hours, with AI drafting the first pass and a person verifying every submission. This is our prior authorization support shaped to uneven ophthalmology coverage, in one paragraph.
Why This Keeps Happening
If crosslinking works and the clinical case is clear, why is coverage still a fight? Because the policy landscape is genuinely uneven. The FDA approved the first crosslinking system for progressive keratoconus in April 2016, and commercial coverage of the approved epi-off protocol has expanded widely since, but the picture is not uniform: Medicare has no national coverage determination for the procedure and evaluates it case by case, and off-label epi-on techniques are routinely excluded. Crosslinking is billed under a Category III CPT code, 0402T, and Category III codes are paid at each payer’s discretion, which is exactly why one plan approves cleanly and another calls the same procedure investigational.
Medicaid is the second half of the problem, and it is where the patients are. Keratoconus often presents in teenagers and young adults, and a large share of those patients are covered by Medicaid, where coverage for crosslinking varies by state and by managed-care plan. A benefit that is covered in one state, or by one plan, may need a prior authorization, specific progression documentation, or a case-by-case review next door. When that variance meets a busy surgical schedule, the coverage detail is the thing that gets assumed instead of confirmed, and closing that gap is what disciplined Medicaid prior authorization support is built to do.
And the cost of getting it wrong is not only financial. Crosslinking is time-sensitive: it halts progression, so a delay while a coverage battle plays out can mean a young patient’s keratoconus advances in the meantime. A denial that is really a policy mismatch is not a billing nuisance; it is a preventable procedure sitting on hold, and the clinical clock does not pause for the appeal. The lost revenue on an unrecovered case is real, and the vision that could have been preserved on schedule is what makes the coverage work worth doing right the first time.
Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:
| What you tried | What actually happened | Who ended up doing the work |
|---|---|---|
| Scheduled first, checked coverage later | Denied after the procedure was on the calendar, especially on Medicaid where the state and plan rule was never confirmed | Whoever booked before verifying |
| Fought an investigational denial on clinical merit | Went nowhere, because the label was a policy gap, not a medical dispute | The surgeon, arguing the wrong point |
| Used one documentation template for every plan | Denied by the plans whose policy wanted different progression evidence or excluded off-label techniques | A template that ignored uneven policy |
| Gave crosslinking auth to a dedicated specialist | Each plan’s policy read first, request built to it, Medicaid confirmed by state, investigational denials appealed with the coverage record | Someone whose whole job it is |
The Solution
So what does “someone whose whole job it is” look like on a crosslinking case? The specialist starts where the practice usually cannot spare the minutes: reading the specific plan’s crosslinking policy before anything is scheduled, whether it covers the FDA-approved epi-off protocol, what progression documentation it requires, and whether it excludes off-label techniques. Then they build the request to that exact policy, so a plan that would approve does not deny on a documentation gap, which is what disciplined prior authorization support is built to prevent before it becomes an appeal.
Because so many keratoconus patients are on Medicaid, the specialist confirms coverage for the patient’s state and plan up front, captures the documentation the plan wants, and files the authorization the way it needs to be filed, so a case-by-case Medicaid rule becomes a prepared request instead of a surprise denial. When a plan calls the approved procedure investigational, they appeal with the coverage record and the plan’s own policy, and the ophthalmology billing behind it is worked cleanly, the way solid ophthalmology medical billing is supposed to run, so an approved case is actually paid.
Behind all of it, AI drafts the first pass and a person verifies. The workflow pulls each plan’s policy, flags the progression and protocol requirements, and assembles the request; a US-licensed nurse or pharmacist reviews the documentation for quality and a specialist owns the Medicaid confirmation and any appeal. Every security control that protects the patient data moving through that process is documented and auditable, covered by a signed BAA, and described on our HIPAA and security page, because moving clinical documentation through a coverage workflow is only safe when the controls are real.
Who Actually Does This Work
Fair question: why would an outsourced team get your crosslinking cases covered better than your own staff? Because reading uneven payer policy, documenting to it, and confirming Medicaid by state is their entire day, not the thing they squeeze between clinic patients. The people working your auths are clinically trained specialists with real US payer experience, working under US-licensed nurse and pharmacist quality review and trained specifically in ophthalmology prior authorization and coverage. They know which plans cover the approved epi-off protocol, how to document progression to a specific policy, how Medicaid crosslinking coverage differs by state, and how to appeal an investigational label with the coverage record. That is not a generalist task handed to whoever is free; it is a specialty.
We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated remote staff working US business hours in your time zone, reachable on your own phone system or a dedicated US number, with a signed BAA and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical practice is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a crosslinking case never stalls because the one person who handles auth is out.
And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified to ISO/IEC 27001:2022, aligned to HIPAA and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.
Put the routine and the people together, and a specific list of things simply stops happening.
Ready to Stop Losing Crosslinking Cases to Coverage Roulette?
How We Permanently Fix the Process
A person alone is not the fix, and neither is a bot alone. The fix is a documented crosslinking-auth workflow that names, per payer and per state Medicaid plan, whether the procedure is covered, what progression documentation each policy wants, its age and diagnosis criteria, and how it treats off-label techniques, all written down and worked the same way before every case. Before we take a single auth for a new practice, we chart your crosslinking denials by payer so we can see where cases are actually being lost, and we build the policy map against that, not against a generic template.
From there the workflow becomes a living playbook rather than tribal knowledge in one coordinator’s head. It records how each plan covers crosslinking, which state Medicaid rules apply, how to document progression to each policy, and the escalation path when a plan calls the approved protocol investigational. It is written down, kept current as payers and states update their policies, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a crosslinking case never waits for one person to come back.
That is the difference between fighting this month’s crosslinking denials and fixing the process for good, and it is what a dedicated prior authorization partner actually buys you. A coordinator leaving used to mean the policy knowledge left with them and the denials came back. Under this model the workflow keeps running, the playbook stays, the backup steps in, and an uneven coverage landscape stops being the thing that quietly costs you cases and delays care.
The Whole Thing in Four Sentences
Corneal crosslinking is hard to get covered because policy is uneven: commercial coverage of the FDA-approved epi-off protocol is now widespread, Medicare has no national coverage determination and decides case by case, and Medicaid varies by state, so approval hinges on the specific plan and the documentation. Scheduling before verifying, fighting an investigational label on clinical merit, or using one template for every plan all fail the same way. The fix is to read each plan’s policy before scheduling, document progression and the approved protocol to it, confirm Medicaid by state up front, and appeal an investigational denial with the coverage record. An ophthalmology and cornea group runs exactly this model with us today, names withheld, no patient data shown.
If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.
Ready to stop losing crosslinking cases to coverage roulette? Try us risk free: two weeks, your real crosslinking denial queue, dedicated specialists reading each plan’s policy and confirming Medicaid before you schedule, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.
One Flat Weekly Rate. 45 Hours of Coverage.
No hourly meters, no setup fees, no long-term contracts. Your dedicated team member covers your desk 45 hours every week, and a trained backup steps in at no charge whenever they are out.
One dedicated remote specialist owning crosslinking and keratoconus authorizations end to end, single-site ophthalmology or cornea practice
5+ remote specialists covering crosslinking and specialty ophthalmology auth across a multi-provider group and several sites
10+ remote specialists, multi-location ophthalmology network, MSO, or PE-backed platform running crosslinking and specialty auth across many providers
45 hours of coverage for less than others charge for 40.
Standard US full-time year: 40 hrs x 52 weeks = 2,080 hours, the federal basis for computing hourly pay per the U.S. Office of Personnel Management. A Staffingly plan: 45 hrs x 52 weeks = 2,340 hours a year, that is 260 additional hours included in your flat rate. $399/week x 52 = $20,748 a year / 2,340 hours = $8.87 per hour. Typical US market rates for healthcare virtual assistants run $9.50 to $13.00 per hour for 40 hours of coverage.
Get Your Crosslinking Cases Covered This Month
You have seen the whole method. The pilot proves it on your own coverage queue, with a tracker your team can watch every day.
Book a 2-Week Risk-Free PilotWant Us to Stop Losing Crosslinking Cases to Coverage Roulette?
Tell us your situation and we will map your crosslinking denials by payer, the Medicaid variance, and the auth workflow behind them. A real person replies in 15-30 minutes.
Frequently Asked Questions
Where the Claims on This Page Come From
Sources & References
- American Academy of Ophthalmology, Corneal Cross-Linking Billing and Reimbursement Guidance. Documentation that crosslinking is reported under Category III CPT code 0402T, that Category III codes are paid at payer discretion, and how coverage and reimbursement vary by payer. aao.org
- U.S. Food and Drug Administration, Corneal Cross-Linking Approval. Record of the April 2016 approval of the first corneal crosslinking system for progressive keratoconus and corneal ectasia. fda.gov
- National Keratoconus Foundation, Crosslinking Coverage Resources. Patient and provider guidance on crosslinking insurance coverage, payer variation, and Medicaid differences by state. nkcf.org
- MGMA Practice Operations and Prior Authorization Resources. Benchmarks and guidance on authorization workload, coverage variation, and patient access for medical group practices. mgma.com
- HFMA Revenue Cycle and Denials Management Resources. Guidance on coverage-related denials, appeals workflow, and the revenue impact of inconsistent payer medical policy. hfma.org